Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome

Launched by IRCCS SAN RAFFAELE · May 29, 2024

Keywords

ClinConnect Summary

The GEDI trial is a study designed to gather information about women who experience acute coronary syndrome (ACS), which includes serious heart conditions like heart attacks and unstable angina. The goal of this research is to understand how ACS affects women differently and to identify factors, such as genetics, that may influence their treatment and recovery. By collecting detailed information from women aged 18 and older who are diagnosed with ACS, researchers hope to uncover important differences that could help improve care for women with heart issues.

To participate in this study, women must be 18 years or older and have been diagnosed with ACS. Unfortunately, those under 18 or who are not willing to sign consent forms or attend follow-up visits will not be eligible. If you choose to take part, you can expect to undergo various tests and evaluations that will help researchers learn more about how ACS presents in women. This information is vital for developing better treatment options and improving health outcomes for women facing these serious heart conditions.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women \>/= 18 years with ACS (STEMI, NSTEMI or Unstable Angina).
• Exclusion Criteria:
• • age \< 18 years and/or unwillingness to sign informed consent and/or unwillingness to make follow-up visits